Pantherics
company
About
Pantherics is a new type of therapy based on modulation of peripheral GABAA receptors.
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $255.84K
- Industries
- Biotechnology,Life Science
- Founded date
- Jan 1, 2019
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Pantherics is a new type of therapy based on modulation of peripheral GABAA receptors.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$480.59K
Pantherics has raised a total of
$480.59K
in funding over 2 rounds. Their latest funding was raised on
Aug 11, 2022 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 11, 2022 | Grant | $255.84K | 1 |
National Institutes of Health
|
— | Detail |
| May 7, 2019 | Grant | $224.75K | 1 |
National Institutes of Health
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
1
Pantherics is funded by 1 investors.
National Institutes of Health
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Institutes of Health
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
